TY - JOUR
T1 - Novel KCNQ2 mutation in a large emirati family with benign familial neonatal seizures
AU - Saadeldin, Imad Y.
AU - Milhem, Reham M.
AU - Al-Gazali, Lihadh
AU - Ali, Bassam R.
N1 - Funding Information:
The authors are grateful to the family of the patient for participating in this study. The laboratories of B.R.A. and L.A.-G. are funded by grants from United Arab Emirates University and the National Research Foundation .
PY - 2013/1
Y1 - 2013/1
N2 - Mutations in voltage-gated potassium channel Kv7.2 are responsible for benign familial neonatal seizures type 1, a rare monogenic autosomal dominant inherited epilepsy syndrome. We describe a novel mutation (c.1126-1127delA) in exon 9 of KCNQ2, the gene encoding for the Kv7.2 channel, in a large Emirati family with benign familial neonatal seizures type 1. The mutation leads to a frameshift at amino acid position 376, triggering loss of function and haploinsufficiency. Patients with this mutation manifest repeated clonic seizures with normal interictal electroencephalograms and favorable prognoses. Signs occur within the first days of age, lingering well into puberty. KCNQ2 mutation screening, alongside genetic counseling, should be included in diagnostic evaluations of neonatal epileptic patients, potentially sparing the need for unnecessary investigations and treatment. To our knowledge, this report is the first of a KCNQ2 mutation in an Emirati family with benign familial neonatal seizures type 1.
AB - Mutations in voltage-gated potassium channel Kv7.2 are responsible for benign familial neonatal seizures type 1, a rare monogenic autosomal dominant inherited epilepsy syndrome. We describe a novel mutation (c.1126-1127delA) in exon 9 of KCNQ2, the gene encoding for the Kv7.2 channel, in a large Emirati family with benign familial neonatal seizures type 1. The mutation leads to a frameshift at amino acid position 376, triggering loss of function and haploinsufficiency. Patients with this mutation manifest repeated clonic seizures with normal interictal electroencephalograms and favorable prognoses. Signs occur within the first days of age, lingering well into puberty. KCNQ2 mutation screening, alongside genetic counseling, should be included in diagnostic evaluations of neonatal epileptic patients, potentially sparing the need for unnecessary investigations and treatment. To our knowledge, this report is the first of a KCNQ2 mutation in an Emirati family with benign familial neonatal seizures type 1.
UR - http://www.scopus.com/inward/record.url?scp=84872040194&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872040194&partnerID=8YFLogxK
U2 - 10.1016/j.pediatrneurol.2012.09.012
DO - 10.1016/j.pediatrneurol.2012.09.012
M3 - Article
C2 - 23290024
AN - SCOPUS:84872040194
SN - 0887-8994
VL - 48
SP - 63
EP - 66
JO - Pediatric Neurology
JF - Pediatric Neurology
IS - 1
ER -